Introduction

Cri Du Chat Syndrome (CdCS), also called 5p- Syndrome can be defined as a rare genetic disorder resulting from a deletion on the short arm of chromosome 5. In terms of symptomatology, its most distinct clinical features include a high-pitched cry resembling a cat, characteristic facial abnormalities, and developmental delays. It is very important to detect CdCS as early as possible so the necessary management and intervention strategies can be put into place. 

Hence, this article will explore the diagnosis methods available for this disease which includes prenatal and postnatal approaches.

Clinical presentation of Cri du chat syndrome

The clinical manifestation of Cri Du Chat Syndrome is quite varied. In addition to the most well-known characteristic that contributed to the name of this disease, the high-pitched cry, individuals may exhibit distinctive facial features such as micrognathia, hypertelorism, and low-set ears.¹ Other common clinical manifestations are growth retardation and microcephaly as well as cardiac anomalies. 

Another important aspect that needs to be considered regarding Cri Du Chat Syndrome is the developmental delay in various areas, including motor skills, speech, and cognitive abilities. Individuals diagnosed with this disease have varying degrees of intellectual disability.¹ Moreover, CdCSis associated with behavioural problems such as hyperactivity, impulsivity, and sometimes self-injurious behaviour can be seen. Additionally, CdCSis can affect sensory processing resulting in feeding difficulties. 

Diagnostic criteria for Cri du chat syndrome

When a person is suspected to suffer from CdCSis, the diagnosis process including the observation of clinical features and genetic testing must be taken into account.

The key clinical criteria include, as previously discussed, the distinctive cry, facial dysmorphisms, and developmental delays.

After these features are recognised the next step is to carry out genetic testing. The tests that are usually performed are chromosomal analysis and molecular genetic testing. These tests can show whether or not there is a chromosomal deletion on chromosome 5. Why is this so important? The clinical features associated with CdCS can be quite similar to other genetic syndromes, but the presence of the deletion on chromosome 5 is a result that confirms that, indeed, the person has CdCS.Chromosomal analysis is usually carried out through other techniques can a technique called karyotyping, which, put into simpler words, enables you to put all the chromosomes in order and identify any abnormalities. This technique is considered a fundamental diagnostic tool for CdCS. 

Additionally, there are other techniques that can be used. One of them is called fluorescence in situ hybridization (FISH). FISH is another way to perform a very precise analysis, that specifically identifies the missing segment of chromosome 5. Another tool that can be used is chromosomal microarray analysis (CMA). The advantage of CMA is that it has a higher resolution detection of genetic abnormalities can precisely identify the deleted region and can potentially be used to gather other relevant genetic data. In some cases, molecular genetic testing may also be used to detect specific genetic mutations associated with CdCS. 

It cannot be stressed enough how big of a difference an accurate diagnosis of CdCS can make. An accurate diagnosis can help in receiving the most appropriate medical management but also early intervention.²

Prenatal diagnosis methods

Let’s explore what prenatal tests could be taken that could indicate that the foetus has CdCS Prenatal diagnosis of CdCS involves screening for foetal abnormalities through ultrasound during pregnancy. There are other prenatal diagnostic methods that can be used but it is important to mention that these techniques are invasive.³ Procedures such as amniocentesis and chorionic villus sampling (CVS) can be performed to directly examine the foetal cells for chromosomal abnormalities, including the deletion associated with CdCS.³ Whether or not these procedures should be performed depends on a lot of factors including patient history, any underlying health conditions and if other tests were inconclusive or the results indicated a potential problem.

Early detection during prenatal screening is extremely important in the case of this disease because it allows for informed decision-making and early intervention strategies.

In the unfortunate case that a diagnosis test shows positive for CdCS an important aspect is offering prenatal genetic counselling. This counselling offers both moral and medical support. It is a chance for expectant parents to ask questions and get a better understanding of the disease and its implications.

The genetic and genomic techniques are rapidly and constantly evolving. In the last few years, some non-invasive prenatal screening methods have started to be used as part of diagnosis. One of these techniques is called cell-free DNA testing (cfDNA). To simplify this amazing, newly discovered technique, this test analyses the DNA that “wanders around” freely in one’s blood, after it is released into the blood, following cell death. This test only requires a sample of sample from which the foetal cfDNA is collected and analysed using various genetic techniques.⁴ In this way, an initial assessment of foetal chromosomal abnormalities can be done in non-invasive way. However, as of now, confirmatory testing through invasive prenatal diagnostic procedures is recommended for definitive diagnosis.³

Postnatal diagnosis methods

If CdCS has not been detected during pregnancy, it is then important to consider the postnatal diagnosis methods available. Postnatal diagnosis of CdCS involves, in the first instance, clinical evaluation followed by genetic testing. Clinical assessment involves the examination of typical physical features and developmental milestones.⁷ If after this assessment it is suspected that the person might have CdCS then it is considered what genetic tests should be carried out for confirmation. This is to avoid any unnecessary tests being performed, as genetics testing is often associated with high costs and can increase the pressure on the laboratory staff.

The diagnosis is confirmed using several genetic tests such as chromosomal analysis, fluorescence in situ hybridisation (FISH), and chromosomal microarray analysis (CMA).⁸ As discussed above, each of these techniques has its pros and cons, and which to use for the specific case is at the discretion of the clinician. Molecular genetic testing may be conducted to test for the specific genetic mutations associated with CdCS Each child with CdCS (or another chromosome disorder) requires an accurate diagnosis for proper medical management and intervention planning.⁴

Early intervention and management strategies

Early intervention is extremely important for individuals diagnosed with CdCS. Even though there is no actual cure for this syndrome yet, early intervention can help the person receive a personal disease management plan and ensure the outcomes are as optimised as possible.

The management of CdCS requires a multidisciplinary approach. Usually, different healthcare professionals such as paediatricians, geneticists, and therapists collaborate in putting together a management plan tailored to the patient’s needs. There are a series of options that are meant to target one of the biggest problems of CdCS, developmental delays.⁵ In addition to speech, physical and occupational therapy, behaviour therapy can potentially be shown to improve communication and physical and occupational therapy can also be shown and prescribed to improve motor and daily living skills.⁶

Challenges and considerations in diagnosis

Several concerns and considerations should be taken into account regarding the diagnosis of CdCS. First, CdCS is a very rare condition with a widely variable expression of phenotypes. 

The first difficulty that can arise in CdCS diagnosis is that it has clinical characteristics similar to other genetic syndromes. However, the treatment needed is different compared to other genetic diseases. Secondly, in some locations, access to genetic testing can be a problem. It means that CdCS is diagnosed late or not diagnosed at all. Thirdly, the emotional and psychological distress of families is also an issue of the CdCS diagnosis. Due to the rare nature of CdCS, most parents who have a child with the condition are exposed to grief and a feeling of guilt. Diagnosis requires many coping mechanisms, particularly support services, and a genetic assistant.

Additionally, another problem is the misdiagnosis or late diagnosis of CdCS. Due to the rarity and variability of CdCS, the symptoms can be misunderstood or missed, which results in misdiagnosis, inappropriate medical measures, and critical interventions administered with delays that, in turn, worsen the overall prognosis and quality of life. Therefore, CdCS is a relatively unknown and difficult-to-recognize disease. 

Improving the diagnosis and treatment for Cri du chat syndrome

New genetic technologies can help diagnose and manage Cri Du Chat Syndrome (CdCS). More research is needed to understand how genes are related to traits and create specific treatments. It's important to keep studying how early treatments work and how people with CdCS stay healthy. It's crucial for doctors, scientists, and support groups to work together to make progress in diagnosing and treating CdCS. Using genetic information and personalized medicine can help give better care and results to people with CdCS. With new technology and teams working together, we can get better at diagnosing, treating, and improving the lives of people with CdCS. 

Healthcare challenges around the world 

Cri Du Chat Syndrome (CdCS) is hard to deal with in many places, especially where healthcare and genetic testing aren't easily available. Differences in healthcare and knowledge make it difficult to diagnose CdCS and give the right care. In some poorer countries, people don't know much about CdCS and can't test for it early. Money and beliefs can stop people from getting special care for genetic conditions. Fixing these healthcare issues requires everyone to work together to improve diagnosis, make people aware, and give everyone the same chances for testing, early help, and all-around care for CdCS. Governments, healthcare groups, support groups, and worldwide organisations must join forces to make healthcare better and help everyone with CdCS.

Summary

In conclusion, the journey to CdCS diagnosis is a complex process that requires vigilance and special knowledge and support.